News
FDA approves landmark pancreatic cancer drug that's shown to improve survival
Summary by The San Francisco Editorial Desk Matthew Perrone and Lauran Neergaard | The Associated Press , as published by NBC Bay Area (KNTV, NBC)
· August 26, 2026
· 1 min read
Photo: NBC Bay Area (KNTV, NBC) · view original
Story provenance No corrections
Summary created by The San Francisco Editorial Desk — automated, rule-governed Byline on source page Matthew Perrone and Lauran Neergaard | The Associated Press, as published by NBC Bay Area (KNTV, NBC) Original story Read at the source Source published Aug 26, 2026 Indexed here Aug 27, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log · Publisher’s note
Key points The company has announced the cost of a one-month supply. A new treatment has been approved for a common form of pancreatic cancer.
A new treatment has been approved for a common form of pancreatic cancer. This approval brings a more effective option to patients. The medication works by blocking a protein that fuels tumor growth.
Patients who took the medication saw improved survival times and fewer severe side effects. The treatment will be available as a daily pill, sold under a specific brand name.
The company has announced the cost of a one-month supply. For more information on this development, further details are available from the source.
More News Today’s briefing Local events
Why this story is here
NBC Bay Area (KNTV, NBC) reported and published this story. The San Francisco selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
About this story
As published by NBC Bay Area (KNTV, NBC) . The San Francisco selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit NBC Bay Area (KNTV, NBC) . Have a tip or correction? Contact the editor .
Category: News Published: August 26, 2026 Source: NBC Bay Area (KNTV, NBC) Reading time: 1 min
Frequently asked about this story
What is this story about? A new treatment has been approved for a common form of pancreatic cancer. This approval brings a more effective option to patients. The medication works by blocking a protein that fuels tumor growth…
When was this published? This article was first published on August 26, 2026 by NBC Bay Area (KNTV, NBC) and curated for The San Francisco readers.
Who reported this story? This story was reported by Matthew Perrone and Lauran Neergaard | The Associated Press at NBC Bay Area (KNTV, NBC). To learn more about how The San Francisco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more News coverage from The San Francisco, or browse our daily briefing and topic hubs .
← Back to all news
More News →
Today’s briefing
Subscribe to newsletter
